The Effects of Hyperhomocysteinemia on the Presence, Extent, and Severity of Coronary Artery Disease

Size: px
Start display at page:

Download "The Effects of Hyperhomocysteinemia on the Presence, Extent, and Severity of Coronary Artery Disease"

Transcription

1 The Effects of Hyperhomocysteinemia on the Presence, Extent, and Severity of Coronary Artery Disease Abdi BOZKURT, 1 MD, Hale TOYAKSI, 2 MD, Esmeray ACARTÜRK, 1 MD, Abdullah TULI, 2 MD, and Murat ÇAYLI, 1 MD SUMMARY Most cross-sectional and case-control studies indicate that an increased plasma total homocysteine (thcy) level is an independent risk factor for coronary artery disease (CAD). However, this is still a controversial issue. Recently, it was reported that the level of thcy is related to the extent and severity of CAD. This study was designed to investigate the relationship between plasma thcy levels and the presence, extent, and severity of CAD. Three hundred and forty-one patients who underwent coronary angiography were included in the study. Of these patients, 195 had CAD and 146 had normal coronary arteries (control group). The mean thcy level was found to be higher in patients with significant CAD (16.4 ± 7.4µmol/L vs 13.2 ± 3.6 µmol/l, P ). This group also had a higher rate of hyperhomocysteinemia (HHcy) (22.6% vs 5.5%, P ). There were positive relationships between thcy levels and male gender (P = 0.03, r = 0.16), smoking (P, r = 0.19), hyperlipidemia (P = 0.006, r = 0.15), and hypertension (P, r = 0.20). Using regression analysis HHcy was determined to be an independent risk factor for CAD (OR = 3.69, CI 95% , P = 0.004). However, HHcy was not an independent risk factor in patients with low cardiovascular risk profiles. There was no relationship between the level of thcy and the severity, extent, and vessel scores of CAD. On the other hand, age and diabetes mellitus were related with all scores of CAD. In conclusion, although hyperhomocysteinemia is an independent risk factor for CAD in our region, it appears to be unrelated to the extent and severity of the disease. (Jpn Heart J 2003; 44: ) Key words: Hyperhomocysteinemia, Risk factor, Coronary artery disease THERE are several risk factors for CAD. In recent years, a high plasma total homocysteine (thcy) level has been proposed as another important risk factor. The mechanism by which high thcy levels lead to CAD remains unclear. Some of the suggested mechanisms are the damaging effects of thcy on endothelium, platelets, coagulation factors, and smooth muscle of the vessel wall, and oxida- From 1 Departments of Cardiology and 2 Departments of Biochemistry, School of Medicine, Çukurova University, Adana, Turkey. Address for correspondence: Abdi Bozkurt, MD, Assistant Professor of Cardiology, Department of Cardiology, School of Medicine, Çukurova University, Adana, Turkey. Received for publication September 5, Revised and accepted November 1,

2 358 BOZKURT, ET AL Jpn Heart J May 2003 tive modification of the LDL-cholesterol. 1,2) The main factors affecting the plasma thcy levels are age, gender, smoking, physical activity, genetic enzyme disorders, race, and nutrition. 3-6) There are controversial results with regard to both thcy being an independent risk factor as well as its effects on the extent and severity of CAD. 7-12) This study was designed to investigate the relationship between plasma thcy levels and CAD in patients from the Southern part of Turkey. METHODS Patients: Three hundred and forty-one patients who underwent coronary angiography were included in the study. Informed consent was obtained from each patient and the study protocol was approved by the Ethics Committee. Major risk factors for CAD like age, gender, family history, hyperlipidemia, hypertension, and diabetes mellitus were determined. Advanced age was defined as an age > 45 years in men and > 55 years in women. A positive family history was defined as coronary artery disease in a parent or sibling noted under the age of 55 for men and 65 for women. Hyperlipidemia was defined as a plasma total cholesterol level 200 mg/dl and/or a LDL-cholesterol level 130 mg/dl or using lipid lowering drugs at the time of investigation. 13) A sustained blood pressure greater than 140 mmhg systolic and 90 mmhg diastolic or the use of antihypertensive drugs at the time of investigation was defined as hypertension. Diabetes mellitus was considered to be present if there was a history of diabetes, fasting blood glucose 126 mg/dl, or the use of an antidiabetic medication. 14) Patients were classified into two risk groups according to their major risk factors as low risk (with 2 or less) and high risk (with 3 and more). Patients who had cancer, hepatic or renal failure (serum creatinine > 1.5 mg/dl), or were using drugs which affect plasma thcy levels such as multivitamins or anticancer agents were excluded. Plasma homocysteine level measurement: Blood was collected from the antecubital vein after a rest period of 30 minutes in the supine position following a 12- hour fast prior to the coronary angiography. Following coagulation for 1 hour at room temperature the samples were centrifuged at 3000 rpm. The plasma was collected and kept at -70 C until analysis. Total L-homocysteine levels were quantified using a fluorescent polarization immunoassay (FIPA) and an Abbott IMX analyzer. Hyperhomocysteinemia (HHcy) was taken as the mean value plus two standard deviations of the control group and defined separately for each gender. 15) Coronary angiography: Coronary angiography and ventriculography were performed by the Judkins technique. Angiographies were interpreted by two cardiologists. Coronary artery disease was defined as a 50% reduction in the internal

3 Vol 44 No 3 HYPERHOMOCYSTEINEMIA AND CORONARY ARTERY DISEASE 359 diameter of the left anterior descending, right or circumflex coronary artery, or their primary branches. Patients without angiographic lesions were considered to be without CAD. Vessel score: Scoring was based on the number of vessels involved and ranged from 0 to 3. Left main coronary artery stenosis was scored as 1 vessel disease. 16) Extent score: This score was developed by Negri, et al 17) and modified by Birnie, et al. 18) The coronary circulation was divided into 15 segments, 8 of which were classified as first-order segments: left main coronary artery, proximal, middle, and distal left anterior descending, proximal, and middle right coronary artery, and proximal and distal circumflex coronary artery. There are 7 secondorder segments: distal right coronary artery, posterior descending branch, obtuse marginal, and posterolateral branches of the circumflex, and the first 2 diagonal branches of the left anterior descending coronary artery. The 8 first-order segments received a score of 1 if there was any evidence of atherosclerosis, and the second-order segments scored 0.5. The overall score was the sum of the individual segment scores and the maximum score was Stenosis score: This was a modified Gensini score, which has been described previously ) The most severe stenosis in each of 8 segments was graded according to severity, that is: a grade of 1 for 1% to 49%, 2 for 50% to 74%, 3 for 75% to 99% reduction in lumen diameter, and 4 for total occlusion. The scores were added together to give a total score out of a theoretical maximum of 32. Statistical analysis: The results were recorded on a 9.0 SPSS statistical program and defined as the mean ± standard deviation. Student s t test was used to analyze the mean age and thcy levels among the groups. The chi-square test was used to analyze other risk factors. The relationship between the risk factors and thcy levels was determined by Pearson's correlation analysis. The parameters showing uneven distribution were analyzed by Spearman's correlation analysis. Multiple logistic regression analysis was used to determine the relationship between the risk factors, HHcy, and CAD. Linear regression analysis was used to determine the angiographic scoring of CAD and related factors. A P value < 0.05 was considered significant. RESULTS Demographic specifications of the patients and levels of thcy: Among the study population, 195 patients had CAD and 146 had normal coronary arteries (control group). The mean age of the patients with CAD were significantly higher than the patients in the control group (52.3 ± 9.8 vs 50.2 ± 9.6, P = 0.046). All the major risk factors leading to CAD were also higher in the CAD group compared to the control group. The mean thcy level was also higher in the CAD group than in the

4 360 BOZKURT, ET AL Jpn Heart J May 2003 control group (16.4 ± 7.4µmol/L vs 13.2 ± 3.6 µmol/l, P ). Hyperhomocysteinemia values were calculated differently for each gender. The cut-off values were determined to be 21.3 µmol/l for males and 17.9 µmol/l for females, and higher levels were considered to be HHcy. Hyperhomocysteinemia was more prevalent in the CAD group than in the control group (22.6% vs 5.5%, P ). The demographic characteristics and cardiovascular risk factors for the patients and controls are shown in Table I. thcy level and hyperhomocysteinemia in patient population subgroups: The mean thcy levels were higher in both the male (P = 0.001) and female (P = 0.002) subgroups of the CAD patients compared to the control group. The thcy levels were higher in males than females in both groups (16.9 ± 7.8 µmol/l vs 14.8 ± 5.7 µmol/l, P = 0.04 and 14.0 ± 3.7 µmol/l vs 12.0 ± 3.0 µmol/l, P = 0.001, respectively). The prevalence of HHcy was the same in the male and female groups (21.7% vs 25.0%, P = 0.6). Regardless of age, the mean plasma thcy levels in the patients were higher than the control group. There was no relation between age and thcy levels in the patients and the control group. In the CAD group, the mean levels of thcy were significantly different in the patients who had previous myocardial infarction (n = 68) and the patients who did not (n = 127) (17.1 ± 8.2 µmol/l and 15.0 ± 5.2 µmol/l respectively, P = 0.03). However, there was no relationship between the prevalence of HHcy and Table I. Controls Demographic Characteristics and Cardiovascular Risk Factors of the Patients and the Patients (n = 195) Controls (n = 146) P Age (years) Gender (female/male) Smoking Hypertension Diabetes mellitus Hyperlipidemia Family history Total cholesterol (mg/dl) LDL-cholesterol (mg/dl) HDL-cholesterol (mg/dl) Triglyceride (mg/dl) Homocysteine (µmol/l) Male (n = 237) Female (n = 104) 50 age (n = 163) > 50 age (n = 178) Hyperhomocysteinemia 52.3 ± / (60.5 %) 68 (34.9 %) 32 (16.4 %) 115 (59.0 %) 72 (36.9 %) ± ± ± ± ± ± ± ± ± (22.6 %) 50.2 ± /94 52 (35.6 %) 30 (20.5 %) 5 (3.4 %) 30 (20.5 %) 10 (6.8 %) ± ± ± ± ± ± ± ± ± (5.5 %)

5 Vol 44 No 3 HYPERHOMOCYSTEINEMIA AND CORONARY ARTERY DISEASE 361 prior MI (P = 0.4, r = 0.06) and the rate of HHcy were similar in both subgroups (24.4% vs 19.1%, P = 0.4). Relationship between risk factors and thcy level: There was a positive but weak relationship between the thcy levels and male gender (P = 0.03, r = 0.16), cigarette smoking (P, r = 0.19), hyperlipidemia (P = 0.006, r = 0.15), and hypertension (P, r = 0.20). The patients with major risk factors in the CAD group had higher levels of thcy compared to the patients in the control group with similar risk factors (Table II). Relationship between CAD and HHcy and major risk factors: Using regression analysis, HHcy was determined to be an independent risk factor for CAD (OR = 3.69, CI 95% , P = 0.004) just like age, gender, smoking, DM, family history, and hyperlipidemia (Table III). When patients were analyzed according to their gender, HHcy was found to be an independent risk factor for both males (OR = 3.62, 95% CI = , P = 0.02) and females (OR = 6.4, 95% CI = , P = 0.004). However, in the subgroup analysis the mean thcy levels of the patients (n = 42) and control group (n = 92) with low risk profiles were similar (14.0 ± 4.9 µmol/l vs 12.8 ± 3.4 µmol/l, P = 0.1). HHcy was not an independent risk factor for the low risk group (OR = 1.32, CI95% , P = 0.7). Relationship between plasma thcy levels and other risk factors with the extent, severity, and vessel scoring of the CAD: It was found that age (P = 0.001, r = 0.25), DM (P = 0.004, r = 0.21), and hypertension (P = 0.02, r = 0.17) were related to the vessel score whereas thcy (P = 0.3, r = 0.07) was not. In the subgroup analysis, neither the low risk (P = 0.6, r = 0.04) nor high risk group (P = 0.2, r = 0.1) thcy was related to the number of vessel involved. The mean vessel scores were 1.84 ± 0.8 and 1.77 ± 0.8 for patients with and without HHcy, respectively (P = 0.6). Patients with 3-vessel disease had significantly higher rates of Table II. Plasma Total Homocysteine Levels in the Patients and Controls with the Same Risk Factor Risk Factors Patients (n = 195) Controls (n = 146) P Smoking Hypertension Diabetes mellitus Hyperlipidemia Family history + (170) (171) + (98) (143) + (37) (304) + (145) (196) + (82) (259) 17.4 ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± (+): present, ( ): absent.

6 362 BOZKURT, ET AL Jpn Heart J May 2003 Table III. Risk Factors for CAD According to Multiple Logistic Regression Analysis Risk Factor Odds ratio 95% Confidence interval P Age Gender Smoking Hypertension Diabetes mellitus Hyperlipidemia Family history HHcy HHcy = hyperhomocysteinemia; CAD = coronary artery disease. Table IV. Comparison of Cardiovascular Risk Factors According to the Number of Stenosed Vessels in Patients with CAD Risk Factor 1 Vessel (n = 82) 2 Vessel (n = 64) 3 Vessel (n = 46) Age (years) Smoking Hypertension Diabetes mellitus Hyperlipidemia Family history Total cholesterol (mg/dl) LDL-cholesterol (mg/dl) HDL-cholesterol (mg/dl) Triglyceride (mg/dl) thcy (µmol/l) HHcy 49.7 ± (65.9 %) 23 (28 %) 8 (9.8 %) 48 (58.5 %) 27 (32.9 %) ± ± ± ± ± (22.0 %) 53.6 ± (60.9 %) 20 (31.3 %) 10 (15.6 %) 34 (53.1 %) 24 (37.5 %) ± ± ± ± ± (23.4 %) 55.4 ± 10.0* 23 (50 %) 24 (52.2)* 14 (30.4 %)* 33 (77.1 %) 20 (43.5 %) ± ±± ± ± ± (23.9 %) thcy = homocysteine; HHcy: hyperhomocysteinemia; CAD = coronary artery disease. *Three-vessel versus one-vessel, P < Three-vessel versus two vessel, P < 0.05 Two-vessel versus one-vessel, P < major risk factors including age, hypertension, DM, and hyperlipidemia compared to patients with 1 vessel disease (Table IV). Linear regression analysis showed a significant relationship between the extent of CAD and age (P = 0.009) and DM (P = 0.006). No relationship was identified between thcy and disease scoring (Table V). The mean extent score was 2.22 ± 1.3 and 2.25 ± 1.3 in patients with and without HHcy, respectively (P = 0.8). The stenosis scoring of the CAD had a relationship with age (P = 0.007) and DM (P = 0.008), however, this relationship was not present with thcy (Table V). The stenosis scores were 6.47 ± 3.6 and 6.61 ± 3.8 for patients with and without HHcy, respectively (P = 0.8). There was no relationship between thcy and

7 Vol 44 No 3 HYPERHOMOCYSTEINEMIA AND CORONARY ARTERY DISEASE 363 Table V. P Values of the Relation Between Risk Factors and the Vessel, Extent, and Stenosis Scores in Patients with CAD Risk Factor Vessel score Extent score Stenosis score Age Smoking Hypertension Diabetes mellitus Hyperlipidemia Family history thcy (µmol/l) thcy = homocysteine; CAD = coronary artery disease. extent and stenosis scoring when the patients were divided into subgroups according to age, gender, and risk profile (P > 0.05). DISCUSSION The relationship between plasma thcy and CAD is still a matter of argument. Most of the cross-sectional and case control studies indicate that the increased level of thcy is an independent risk factor for CAD. 7-8,22-26) Some prospective studies have also showed that an increase in thcy is an indicator for cardiovascular mortality and new coronary artery events ) However, in some case controlled and prospective studies it was reported that there is no relationship between thcy and CAD. 9-11,27) In this study, we determined that HHcy, similar to known major risk factors, is an independent risk factor for CAD and increases the risk of CAD by 3.69 fold. This result is consistent with the literature indicating a 1.3 to 5.2 fold increase in the risk. 28) HHcy was found to be an independent risk factor for both males and females in the subgroup analyses. There are many possible reasons for the controversial results on the relation between HHcy and CAD. First, the factors affecting the level of thcy are different in every population. Factors like nutrition habits, genetic factors, life styles, and race can affect thcy levels. 3-6) Also, both the thcy level and CAD to which is related are multifactorial. In a study conducted in India, patients with and without CAD were found to have similar levels of thcy of around 18 µmol/l. 9) However, among Indians living in England, although in both the CAD and control groups the levels of thcy were determined to be lower (12.0 µmol/l and 10.8 µmol/l), it was concluded that thcy was an independent risk factor. 23) A second reason is the difference in the methodology of the studies. Although in most studies the diag-

8 364 BOZKURT, ET AL Jpn Heart J May 2003 nosis of CAD was made with criteria of 50% stenosis of vessel diameter, in others this value was considered to be 70% - 75%. 7,9,22,23) Also, some subjects did not undergo coronary angiography. 7,9) One other important point is the difference in the definition of HHcy. In many studies HHcy is accepted as being greater than the sum of the mean value of the normal population and 2 standard deviations. 15,28) However, in some studies HHcy was defined as the thcy level, which is above the 75% or 90% percentile of the normal population. 7,11) Furthermore, the clinical condition of the patient during the measurement of thcy levels is an important factor. In some studies it was reported that these levels were measured during acute coronary events and this could affect the results. 28) In a recent study it was shown that in patients with premature CAD, although the thcy levels were not higher than normal controls, HHcy and a history of myocardial infarction (MI) were found to be related and it was proposed that HHcy might be important not in the development of CAD, but rather in acute coronary thrombosis. 10) Ethnic and geographic differences, nutritional habits, and genetic polymorphism are factors which can affect the results. 3-6,29) In our population there is a relationship between thcy and CAD independent of age and gender. Furthermore, HHcy appears to be the fourth major risk factor following family history, DM, and hyperlipidemia. Donner, et al 30) have found that in low risk patient groups and patients under the age of 50 the incidence of HHcy was not significantly high. They concluded that the CAD and HHcy relationship reported in other studies was actually a result of other primary risk factors. A meta-analysis showed that although the effect of HHcy in the development and progression of CAD might be less important in the long term, it is still too early to conclude that HHcy is not an important risk factor. It was also stated that the effects of thcy could be masked by other risk factors. 12) We also found that in low risk profile patients the thcy levels were not higher than the control group and HHcy was not an independent risk factor. But this subgroup consisted of only a few patients. The mean thcy level of the patients than smoke or have hypertension or hyperlipidemia was higher than that of the control subjects with the same risk factors. For these reasons, in patients with a low risk profile it may not be appropriate to conclude that HHcy is not an independent risk factor for CAD. Also, in a study involving a small patient population formed of low risk profile patients, there was a significant relationship between thcy levels and CAD. 31) However, in the literature there are no adequate data to support that HHcy is an independent risk factor in patients with a low risk profile. The normal plasma thcy level is accepted to be 5-15 µmol/l although in many studies a range between µmol/l is commonly used. 27,32) In the patient populations this value was found to be between 7.6 and 16.4 µmol/l. 5,32)

9 Vol 44 No 3 HYPERHOMOCYSTEINEMIA AND CORONARY ARTERY DISEASE 365 In one study this level was found to be around 18 µmol/l in both the patient and control groups and this was attributed to nutritional habits. 9) The values we present in this paper for both the CAD and the control groups are within the range found in the literature. We did not find a relationship between age and thcy levels. This might be attributed to the mean age distributions of our CAD and control groups, which were 52 and 50 years, respectively. Similarly, some studies show that there is no relationship between age and thcy levels. 7,25) Also, in these studies the mean age was around 50 to 54 years. It is known that in males the thcy levels are 11% - 22% higher than in females. 5,8) We also found that the thcy levels in males were 14% higher than in females in both the CAD and control groups. This finding is attributed to estrogen being a factor that lowers thcy levels in females. 33) The lower levels of B6, folate, and cobalamine in meles might be another reason for this phenomenon. 4) We also identified a weak relation between thcy levels and smoking. However, the mechanism by which smoking increases thcy levels is unknown. Some possible mechanisms might be decreases in plasma thiol, folate, B12, and B6 levels due to smoking. 34,35) Although most studies failed to identify a relationship between hypertension and lipid profiles with thcy, 7,8,24,25) some epidemiologic studies reported the existence of this phenomenon. 6,36) We also identified a significant but weak relationship between hypertension and high total cholesterol levels with thcy. The effect of MI on thcy is controversial. It was reported that in the first 24 hours of the MI the thcy level was 40% lower than the 72-hour value, followed by an increase after the acute phase which lasts for 6 to 8 weeks. 37) Nikfardjam, et al 10) showed a relationship between history of MI and HHcy. Nygard, et al 24) reported that in patients with a history of MI the levels of thcy were elevated and this eleration was attributed to an increase in acute events. In our study even though we found that the thcy levels were higher in patients with a history of MI, there was no difference in the rate of HHcy. In recent years, it has been reported that the level of thcy may be related to the extent, severity, and number of vessels involved in CAD and may be important in the progression of the disease. 7,38) A prospective study based on a definition of CAD of 50% stenosis showed that thcy levels are weakly related with vessel score unlike dyslipidemia which is strongly related with vessel score. 24) Montalescot, et al 38) accepted > 75% stenosis as the criteria for a diagnosis of CAD and found a weak but significant relationship between the number of vessels involved and the level of thcy. In a study involving only male patients in which the criteria for CAD was > 75% stenosis, the level of thcy was found to be higher in patients with 3 vessel disease than in patients with 1 or 2 vessel disease. 7) Chao, et al 8) accepted the border for CAD as 70% stenosis and found that the thcy levels were significantly higher in patients with 3-vessel disease than in

10 366 BOZKURT, ET AL Jpn Heart J May 2003 patients with 1 or 2-vessel disease. They also found a relationship between extent and stenosis scoring with the level of thcy. There are also studies stating there is no relationship between thcy levels and the extent, severity, and number of vessels involved. Kang, et al 39) who considered the CAD criteria to be > 70% stenosis and Wilcken, et al 40) who took the CAD criteria to be 50% stenosis, reported there was no relationship between thcy levels and disease severity. A study showed that thcy levels are related with the vessel and extent scores of CAD in patients with a low risk profile unlike in patients with a high risk profile. 31) In our study, we did not find a relationship between the thcy levels and the extent, severity, and number of vessels involved in the CAD. This might be due to the number of patients. However, in the literature the study group sizes vary between 70 and 201 patients. 7,31) On the other hand, there was a relationship between major risk factors such as age and DM with the scores for extent, severity, and number of vessels involved. Controversial results between plasma thcy levels and the extent and severity of CAD might be related to the different narrowing percentages for vessels used in defining CAD. Another possible reason is that the relation between the extent and severity of CAD could be dependent on geographic, demographic, nutrition, and genetic differences. On the other hand, risk factors that have an effect on the progression of CAD may differ according to the characteristics of the populations and patients groups. CONCLUSION Although hyperhomocysteinemia is an independent risk factor for CAD in our region, it appears to be unrelated to the extent and severity of the disease. REFERENCES 1. McCully KS. Homocysteine and vascular disease. Nat Med 1996; 2: Thambyrajah J, Townend JN. Homocysteine and atherothrombosis mechanisms for injury. Eur Heart J 2000; 21: Kraus JP. Biochemistry molecular genetics of cystathionine beta-synthase deficiency. Eur J Pediatr 1998; 157: S Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993; 270: Senaratne MP, MacDonald K, DeSilva D. Possible ethnic differences in plasma homocysteine levels associated with coronary artery disease between South Asian and East Asian immigrants. Clin Cardiol 2001; 24: Nygard O, Volsett SE, Refsum H, et al. Total plasma homocysteine and cardiovascular risk profile: the Hordaland Homocysteine Study. JAMA 1995; 274: Yoo JH, Park JE, Hong KP, et al. Moderate hyperhomocyst(e)inemia is associated with the presence of coronary artery disease and severity of coronary atherosclerosis in Koreans. Thromb Res 1999; 94: Chao CL, Tsai HH, Lee CM, et al. The graded effect of hyperhomocysteinemia on the severity and extent of coronary atherosclerosis. Atherosclerosis 1999; 147:

11 Vol 44 No 3 HYPERHOMOCYSTEINEMIA AND CORONARY ARTERY DISEASE Sastry BKS, Indira N, Anand B, Kedarnath, Surya Prabha B, Soma Raju B. A case-control study of plasma homocysteine levels in South Indians with and without coronary artery disease. Indian Heart J 2001; 53: Nikfardjam M, Graf S, Hornykewycz S, et al. Homocysteine plasma levels in young patients with coronary artery disease. Relation to history of acute myocardial infarction and anatomical extent of disease. Thromb Res 2001; 103: S Verhoef P, Kok FJ, Kruyssen ACM, et al. Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1997; 17: Cleophas TJ, Hornstra N, van Hoogstraten B, Van der Meulen J. Homocysteine, a risk factor for coronary artery disease or not? A Meta analysis. Am J Cardiol 2000; 86: Executive summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Cholesterol in Adults (Adult Treatment Panel III). JAMA : American Diabetes Association, The Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1999; 22 : Palma Reis M, Azinheira J, Reis HP, Bordalo A, et al. Homocysteinemia after methionine overload as a coronary disease risk factor: importance of age and homocysteine levels. Coronary Artery Disease 1995; 6: Sullivan DR, Marwick TH, Freedman SB. A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors. Am Heart J 1990; 119: Negri M, Sheiban I, Arigliano P, et al. Interrelation between angiographic severity of coronary artery disease and plasma levels of insulin, C-peptide, and plasminogen activator inhibitor-1. Am J Cardiol 1993; 72: Birnie DH, Holme ER, McKay IC, Hood S, McColl KEL, Hillis WS. Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Eur Heart J 1998; 19: Gensini GG. Coronary arteriography. Mount Kisco, New York: Futura Publishing Co, Reardon MF, Nestel PJ, Craig IH, Harper RW. Lipoprotein predictors of the severity of coronary artery disease. Circulation 1985; 71: Austen WG, Edwards JE, Frye RL, et al. A reporting system on patient evaluation for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975; 51: Van den Brandhof WE, Haks K, Schouten EG, Verhoef P. The relation between plasma cysteine, plasma homocysteine and coronary atherosclerosis. Atherosclerosis 2001; 157: Chambers JC, Obeid OA, Refsum H, et al. Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet 2000; 355: Nygard O, Nordrehaug JE, Refsum. H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Eng J Med 1997; 337: Whincup PH, Refsum H, Perry IJ, et al. Serum total homocysteine and coronary heart disease: prospective study in middle aged men. Heart 1999; 82: Aksoy M, Öç M, Aksoy N, et al. Plasma homocysteine, folate and vitamin B12 levels as risk factors for coronary artery disease in a Turkish cohort. Arc Turkish Soc Cardiol 2000; 28: Folsom AR, Nieto FJ, Mc Govern PG, et al. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphism, and B vitamins. The Atherosclerotic Risk in Communities (ARIC) Study. Circulation 1998; 98: Christen WG, Ajani UA, Glyn RJ, Hennekens CH. Blood levels of homocysteine and increased risks of cardiovascular disease. Arch Intern Med 2000; 160: Gudnason V, Stansbie D, Scott J, Bowron A, Nicaud V, Humphries S. C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): its frequency and impact on plasma homocysteine concentration in different European populations. Atherosclerosis 1998; 136: Donner MG, Klein GK, Mathes PB, Schwandt P, Richter WO. Plasma total homocysteine levels in patients with early-onset coronary heart disease and low cardiovascular risk profile. Metabolism 1998; 47: Tsai WC, Li YH, Tsai LM, et al. Correlation of homocysteine levels with the extent of coronary atherosclerosis in patients with low cardiovascular risk profiles. Am J Cardiol 2000; 85:

12 368 BOZKURT, ET AL Jpn Heart J May Israelsson B, Brattstrom LE, Hultberg BL. Homocysteine and myocardial infarction. Atherosclerosis 1998; 71: Morris K. Higher estrogen level linked to decreased homocysteine concentration in women. Am J Epidemiol 2000; 152: Mansoor MA. Bergmark C, Svardal AM, Lonning PE, Ueland PM. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Arterioscler Thromb Vasc Biol 1995; 15: Piyathilake CJ, Macalous M, Hine RJ, Richards EW, Krumdieck CL. Local and systemic effects of cigarette smoking on folate and vitamin B-12. Am J Clin Nutr 1994; 60: Jacques PF, Bostom AG, Wilson PW, Rich S, Rosenberg IH, Selhub J. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr 2001; 73: Egerstron W, Sillberg J, Crooks R, Ray C, Xie L, Dudman N. Serial measures of plasma homocysteine after acute myocardial infarction. Am J Cardiol 1996; 77: Montalescot G, Ankri A, Chadefaux-Vekemans B, et al. Plasma homocysteine and extent of atherosclerosis in patients with coronary artery disease. Int J Cardiol 1997; 60: Kang SS, Passen EL, Ruggie N, Wong PWK, Sora H. Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease. Circulation 1993; 88: Wilcken DEL, Wang XL, Sim AS, McCredie RM. Distribution in healthy and coronary populations of the methylenetetrahydrofolate reductase (MTHFR) C677T mutation. Arterioscler Thromb Vasc Biol 1996; 16:

Predictors of Change in Plasma Total Cysteine: Longitudinal Findings from the Hordaland Homocysteine Study

Predictors of Change in Plasma Total Cysteine: Longitudinal Findings from the Hordaland Homocysteine Study Clinical Chemistry 49:1 113 120 (2003) Lipids, Lipoproteins, and Cardiovascular Risk Factors Predictors of Change in Plasma Total Cysteine: Longitudinal Findings from the Hordaland Homocysteine Study Lina

More information

REVIEW ARTICLE. Blood Levels of Homocysteine and Increased Risks of Cardiovascular Disease

REVIEW ARTICLE. Blood Levels of Homocysteine and Increased Risks of Cardiovascular Disease Blood Levels of Homocysteine and Increased Risks of Cardiovascular Disease Causal or Casual? REVIEW ARTICLE William G. Christen, ScD; Umed A. Ajani, MBBS; Robert J. Glynn, ScD; Charles H. Hennekens, MD

More information

in a population with low plasma

in a population with low plasma 518 Cardiology, Hacettepe University Faculty of Medicine, Ankara 06100, Turkey S L Tokgözoğlu E Atalar K Aytemir N Özer K Övünç S Kes Paediatric Genetics, Hacettepe University Faculty of Medicine M Alikaşifoğlu

More information

Association between Plasma Homocysteine Concentrations and Carotid Intima-Media Thickness in Patients with Coronary Artery Disease

Association between Plasma Homocysteine Concentrations and Carotid Intima-Media Thickness in Patients with Coronary Artery Disease Association between Plasma Homocysteine Concentrations and Carotid Intima-Media Thickness in Patients with Coronary Artery Disease ROXANA BUZAŞ, CORINA ŞERBAN, IOANA SUCEAVA, DANIEL LIGHEZAN University

More information

One third to one half of the variation in vascular disease

One third to one half of the variation in vascular disease Plasma Homocysteine Predicts Mortality Independently of Traditional Risk Factors and C-Reactive Protein in Patients With Angiographically Defined Coronary Artery Disease Jeffrey L. Anderson, MD; Joseph

More information

P H Whincup, H Refsum, I J Perry, R Morris, M Walker, L Lennon, A Thomson, P M Ueland, S B J Ebrahim

P H Whincup, H Refsum, I J Perry, R Morris, M Walker, L Lennon, A Thomson, P M Ueland, S B J Ebrahim 448 Cardiovascular Research Unit, Department of Primary Care and Population Sciences, Royal Free Hospital School of Medicine, London NW3 2PF, UK P H Whincup R Morris M Walker L Lennon A Thomson S B J Ebrahim

More information

Homocysteine and ischaemic stroke in men: the Caerphilly study

Homocysteine and ischaemic stroke in men: the Caerphilly study J Epidemiol Community Health 2001;55:91 96 91 Homocysteine and ischaemic stroke in men: the Caerphilly study U B Fallon, P Elwood, Y Ben-Shlomo, J B Ubbink, R Greenwood, G Davey Smith Department of Social

More information

A. Enbergs, R. Bürger, H. Reinecke, M. Borggrefe, G. Breithardt and S. Kerber

A. Enbergs, R. Bürger, H. Reinecke, M. Borggrefe, G. Breithardt and S. Kerber European Heart Journal (2) 21, 45 52 Article No. euhj.1999.1763, available online at http://www.idealibrary.com on Prevalence of coronary artery disease in a general population without suspicion of coronary

More information

The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India

The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India eissn: 09748369, www.biolmedonline.com The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India M Estari, AS Reddy, T Bikshapathi,

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Kavousi M, Leening MJG, Nanchen D, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines

More information

Plasma homocysteine concentrations in a Belgian school-age population 1 3

Plasma homocysteine concentrations in a Belgian school-age population 1 3 Plasma homocysteine concentrations in a Belgian school-age population 1 3 Corinne De Laet, Jean-Claude Wautrecht, Daniel Brasseur, Michèle Dramaix, Jean-Marie Boeynaems, Jean Decuyper, and André Kahn ABSTRACT

More information

1. Which one of the following patients does not need to be screened for hyperlipidemia:

1. Which one of the following patients does not need to be screened for hyperlipidemia: Questions: 1. Which one of the following patients does not need to be screened for hyperlipidemia: a) Diabetes mellitus b) Hypertension c) Family history of premature coronary disease (first degree relatives:

More information

Hyperhomocystinemia in patients with coronary artery disease

Hyperhomocystinemia in patients with coronary artery disease Brazilian Journal of Medical and Biological Research (2006) 39: 455-463 Hyperhomocystinemia and coronary disease ISSN 0100-879X 455 Hyperhomocystinemia in patients with coronary artery disease J.R. Faria-Neto

More information

PATTERN OF ANGIOGRAPHIC FINDINGS IN YOUNG PATIENTS PRESENTING WITH ACUTE ST SEGMENT ELEVATION MYOCARDIAL INFARCTION

PATTERN OF ANGIOGRAPHIC FINDINGS IN YOUNG PATIENTS PRESENTING WITH ACUTE ST SEGMENT ELEVATION MYOCARDIAL INFARCTION Pak Heart J ORIGINAL ARTICLE PATTERN OF ANGIOGRAPHIC FINDINGS IN YOUNG PATIENTS PRESENTING WITH ACUTE ST SEGMENT ELEVATION MYOCARDIAL INFARCTION Burhan Akhtar, Nauman Ali, Rana Kashif - Department Of Cardiology,

More information

PhD, Mesut DEMIR, 1. MD, Mustafa DEMIRTAS, Murat ÇAYLI, 1 MD, Cumhur ALHAN, 1 MD, and Fikri BASLAMISLI,

PhD, Mesut DEMIR, 1. MD, Mustafa DEMIRTAS, Murat ÇAYLI, 1 MD, Cumhur ALHAN, 1 MD, and Fikri BASLAMISLI, Experimental Studies Prothrombin 20210GA and Factor V Leiden Mutations in Patients Less Than 55 Years Old With Myocardial Infarction Yurdaer DÖNMEZ, 1 MD, Mehmet KANADASI, 1 MD, Kahraman TANRIVERDI, 2,3

More information

Correlation analysis between 25-hydroxyvitamin D3, vitamin B12 and vitamin C and endothelial function of patients with CHD

Correlation analysis between 25-hydroxyvitamin D3, vitamin B12 and vitamin C and endothelial function of patients with CHD 418 Correlation analysis between 25-hydroxyvitamin D3, vitamin B12 and vitamin C and endothelial function of patients with CHD XIAOMING QIN 1, LEI QIN 2, JIACHEN LUO 1, BAOXIN LIU 1, JINLONG ZHAO 1, HONGQIANG

More information

The Framingham Coronary Heart Disease Risk Score

The Framingham Coronary Heart Disease Risk Score Plasma Concentration of C-Reactive Protein and the Calculated Framingham Coronary Heart Disease Risk Score Michelle A. Albert, MD, MPH; Robert J. Glynn, PhD; Paul M Ridker, MD, MPH Background Although

More information

METHYLENETETRAHYDROFOLATE REDUCTASE GENE AMONG THE JAPANESE

METHYLENETETRAHYDROFOLATE REDUCTASE GENE AMONG THE JAPANESE Jpn J Human Genet 41, 247 251, 1996 Short Communication A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE GENE AMONG THE JAPANESE POPULATION Hisahide NISHIO, L* Myeong Jin LEE, ~ Motoko FuJlI, 1

More information

Epidemiologic and clinical comparison of renal artery stenosis in black patients and white patients

Epidemiologic and clinical comparison of renal artery stenosis in black patients and white patients ORIGINAL ARTICLES Epidemiologic and clinical comparison of renal artery stenosis in black patients and white patients Andrew C. Novick, MD, Safwat Zald, MD, David Goldfarb, MD, and Ernest E. Hodge, MD,

More information

Serum Creatinine and Blood Urea Nitrogen Levels in Patients with Coronary Artery Disease

Serum Creatinine and Blood Urea Nitrogen Levels in Patients with Coronary Artery Disease Serum Creatinine and Blood Urea Nitrogen Levels in Patients with Coronary Artery Disease MAK Akanda 1, KN Choudhury 2, MZ Ali 1, MK Kabir 3, LN Begum 4, LA Sayami 1 1 National Institute of Cardiovascular

More information

Research Article Relation between Apolipoprotein E Gene Polymorphism and Severity of Coronary Artery Disease in Acute Myocardial Infarction

Research Article Relation between Apolipoprotein E Gene Polymorphism and Severity of Coronary Artery Disease in Acute Myocardial Infarction Cardiology Research and Practice Volume 2015, Article ID 363458, 4 pages http://dx.doi.org/10.1155/2015/363458 Research Article Relation between Apolipoprotein E Gene Polymorphism and Severity of Coronary

More information

Cho et al., 2009 Journal of Cardiology (2009), 54:

Cho et al., 2009 Journal of Cardiology (2009), 54: Endothelial Dysfunction, Increased Carotid Artery Intima-media Thickness and Pulse Wave Velocity, and Increased Level of Inflammatory Markers are Associated with Variant Angina Cho et al., 2009 Journal

More information

TCTAP Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI

TCTAP Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI Indian TUXEDO Trial In Medically Treated Diabetics Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI Executive Director and Dean Escorts Heart Institute & Medical Research Center and Fortis Hospitals, New Delhi

More information

LDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC

LDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC Am J Cardiol (2004);94:729-32 Relation of degree of physical activity to coronary artery calcium score in asymptomatic individuals with multiple metabolic risk factors M. Y. Desai, et al. Ciccarone Preventive

More information

Effects of Statins on Endothelial Function in Patients with Coronary Artery Disease

Effects of Statins on Endothelial Function in Patients with Coronary Artery Disease Effects of Statins on Endothelial Function in Patients with Coronary Artery Disease Iana I. Simova, MD; Stefan V. Denchev, PhD; Simeon I. Dimitrov, PhD Clinic of Cardiology, University Hospital Alexandrovska,

More information

Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY

Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY MCC-006 POST GRADUATE DIPLOMA IN CLINICAL CARDIOLOGY (PGDCC) 00269 Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY Time : 2 hours Maximum Marks : 60 Note : There will be multiple

More information

A Study of cardiovascular risk factors correlation with the angiographic severity of coronary artery disease using Syntax score

A Study of cardiovascular risk factors correlation with the angiographic severity of coronary artery disease using Syntax score IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 15, Issue 1 Ver. IV (Jan. 2016), PP 21-28 www.iosrjournals.org A Study of cardiovascular risk factors

More information

Correlation of Serum Homocysteine Levels with the Severity of Coronary Artery Disease

Correlation of Serum Homocysteine Levels with the Severity of Coronary Artery Disease Ind J Clin Biochem (July-Sept 2014) 29(3):339 344 DOI 10.1007/s12291-013-0373-5 ORIGINAL ARTICLE Correlation of Serum Homocysteine Levels with the Severity of Coronary Artery Disease Vijetha Shenoy Veena

More information

Title for Paragraph Format Slide

Title for Paragraph Format Slide Title for Paragraph Format Slide Presentation Title: Month Date, Year Atherosclerosis A Spectrum of Disease: February 12, 2015 Richard Cameron Padgett, MD Executive Medical Director, OHVI Pt RB Age 38

More information

Vascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital

Vascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital Vascular disease. Structural evaluation of vascular disease Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital resistance vessels : arteries

More information

2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium. Seoul National University Hospital Cardiovascular Center

2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium. Seoul National University Hospital Cardiovascular Center 2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium Does Lt Late Cth Catch up Exist Eiti in DES? : Quantitative Coronary Angiography Analysis Kyung Woo Park, MD Cardiovascular

More information

and Folic Acid in Type II Diabetes Mellitus Patients.

and Folic Acid in Type II Diabetes Mellitus Patients. Research Article ISSN: 974-6943 M. Prabhuet al. / Journal of Pharmacy Research 214,8(1),1398-145 Available online through http://jprsolutions.info Investigation of the Effect of on the Level of Plasma

More information

LIPIDS AND CHOLESTEROL - RISK FACTORS TO A POLICE UNIT FROM BRASOV

LIPIDS AND CHOLESTEROL - RISK FACTORS TO A POLICE UNIT FROM BRASOV Bulletin of the Transilvania University of Braşov Series VI: Medical Sciences Vol. 4 (53) No. 2-2011 LIPIDS AND CHOLESTEROL - RISK FACTORS TO A POLICE UNIT FROM BRASOV C. DOBRESCU 1 I. MOLEAVIN 1 Abstract:

More information

Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men

Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men John C Chambers, Omar A Obeid, Helga Refsum, Per Ueland, David Hackett, James Hooper, Rebecca M

More information

Diabetes Mellitus: A Cardiovascular Disease

Diabetes Mellitus: A Cardiovascular Disease Diabetes Mellitus: A Cardiovascular Disease Nestoras Mathioudakis, M.D. Assistant Professor of Medicine Division of Endocrinology, Diabetes, & Metabolism September 30, 2013 1 The ABCs of cardiovascular

More information

High Sensitive C-Reactive Protein (hs-crp) and its Correlation with Angiographic Severity of Coronary Artery Disease (CAD)

High Sensitive C-Reactive Protein (hs-crp) and its Correlation with Angiographic Severity of Coronary Artery Disease (CAD) ORIGINAL ARTICLE JIACM 2007; 8(3): 217-21 High Sensitive C-Reactive Protein (hs-crp) and its Correlation with Angiographic Severity of Coronary Artery Disease (CAD) Tenzin Nyandak*, Arun Gogna**, Sandeep

More information

Elevated serum homocysteine level has a positive correlation with serum cardiac troponin I in patients with acute myocardial infarction

Elevated serum homocysteine level has a positive correlation with serum cardiac troponin I in patients with acute myocardial infarction Bangladesh Med Res Counc Bull 2012; 38: 9-13 Elevated serum homocysteine level has a positive correlation with serum cardiac troponin I in patients with acute myocardial infarction Abstract Alam N, Khan

More information

JMSCR Vol 06 Issue 12 Page December 2018

JMSCR Vol 06 Issue 12 Page December 2018 www.jmscr.igmpublication.org Impact Factor (SJIF): 6.379 Index Copernicus Value: 79.54 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v6i12.115 Evaluation of Carotid Intima

More information

Low fractional diastolic pressure in the ascending aorta increased the risk of coronary heart disease

Low fractional diastolic pressure in the ascending aorta increased the risk of coronary heart disease (2002) 16, 837 841 & 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh ORIGINAL ARTICLE Low fractional diastolic pressure in the ascending aorta increased the risk

More information

Know Your Number Aggregate Report Single Analysis Compared to National Averages

Know Your Number Aggregate Report Single Analysis Compared to National Averages Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics

More information

Vascular Inflammation and Angiographic Severity of Coronary Artery Disease in Young Asian Indians

Vascular Inflammation and Angiographic Severity of Coronary Artery Disease in Young Asian Indians Original Article JCDR Vascular Inflammation and Angiographic Severity of Coronary Artery Disease in Young Asian Indians Imran Ahmed **, Achyut Sarkar *, Arindam Pande **, Naveen Chandra GS **, Shailesh

More information

VENOUS THROMBOEMBOLISM AND CORONARY ARTERY DISEASE: IS THERE A LINK?

VENOUS THROMBOEMBOLISM AND CORONARY ARTERY DISEASE: IS THERE A LINK? VENOUS THROMBOEMBOLISM AND CORONARY ARTERY DISEASE: IS THERE A LINK? Ayman El-Menyar (1), MD, Hassan Al-Thani (2),MD (1)Clinical Research Consultant, (2) Head of Vascular Surgery, Hamad General Hospital

More information

REAGENTS. RANDOX sdldl CHOLESTEROL (sdldl-c) SIZE MATTERS: THE TRUE WEIGHT OF RISK IN LIPID PROFILING

REAGENTS. RANDOX sdldl CHOLESTEROL (sdldl-c) SIZE MATTERS: THE TRUE WEIGHT OF RISK IN LIPID PROFILING REAGENTS RANDOX sdldl CHOLESTEROL (sdldl-c) SIZE MATTERS: THE TRUE WEIGHT OF RISK IN LIPID PROFILING Randox sdldl Cholesterol (sdldl-c) Size Matters: The True Wight of Risk in Lipid Profiling 1. BACKGROUND

More information

A: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups

A: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups A: Epidemiology update Evidence that LDL-C and CRP identify different high-risk groups Women (n = 27,939; mean age 54.7 years) who were free of symptomatic cardiovascular (CV) disease at baseline were

More information

Review of guidelines for management of dyslipidemia in diabetic patients

Review of guidelines for management of dyslipidemia in diabetic patients 2012 international Conference on Diabetes and metabolism (ICDM) Review of guidelines for management of dyslipidemia in diabetic patients Nan Hee Kim, MD, PhD Department of Internal Medicine, Korea University

More information

The Diabetes Link to Heart Disease

The Diabetes Link to Heart Disease The Diabetes Link to Heart Disease Anthony Abe DeSantis, MD September 18, 2015 University of WA Division of Metabolism, Endocrinology and Nutrition Oswald Toosweet Case #1 68 yo M with T2DM Diagnosed DM

More information

Hyperhomocysteinaemia in Black patients with cerebral thrombosis

Hyperhomocysteinaemia in Black patients with cerebral thrombosis Q J Med 1997; 90:635-639 Hyperhomocysteinaemia in Black patients with cerebral thrombosis R. DELPORT 1, J.B. UBBINK\ W.J.H. VERMAAK 1, H. ROSSOUW 1, P.J. BECKER 2 andj. JOUBERT 3 * From the ^Department

More information

Objective Calcium score carotid IMT hs-crp

Objective Calcium score carotid IMT hs-crp P3952 Role of coronary calcium score, carotid intima-media thickness and C-reactive protein in predicting extent of coronary artery disease in young patients. Bedside Poster P3952 Role of coronary calcium

More information

Microalbuminuria As Predictor Of Severity Of Coronary Artery Disease In Non-Diabetic Patients:

Microalbuminuria As Predictor Of Severity Of Coronary Artery Disease In Non-Diabetic Patients: ISPUB.COM The Internet Journal of Cardiology Volume 9 Number 1 Microalbuminuria As Predictor Of Severity Of Coronary Artery Disease In Non-Diabetic Patients: F Aziz, S Penupolu, S Doddi, A Alok, S Pervaiz,

More information

Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms

Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms QQ QR/RR n = 36 n = 80 Men (%) 20 (55) 54 (67) 0.216 Age (years) 57 ± 10 56 ±

More information

Clinical Importance of MTHFR Gene Polymorphism in Coronary Artery Disease: A Study from India

Clinical Importance of MTHFR Gene Polymorphism in Coronary Artery Disease: A Study from India Human Journals Research Article September 2018 Vol.:13, Issue:2 All rights are reserved by Alpana Saxena et al. Clinical Importance of MTHFR Gene Polymorphism in Coronary Artery Disease: A Study from India

More information

Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease

Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease Gjin Ndrepepa, Tomohisa Tada, Massimiliano Fusaro, Lamin King, Martin Hadamitzky,

More information

Association of B vitamins status and homocysteine levels in elderly Taiwanese

Association of B vitamins status and homocysteine levels in elderly Taiwanese Asia Pac J Clin Nutr 2005; 14 (3):250-255 250 Original Article Association of B vitamins status and homocysteine levels in elderly Taiwanese Kuan-Ju Chen MS, 1,2 Wen-Harn Pan PhD, 1 Feili-Lo Yang PhD,

More information

Impact of Body Mass Index and Metabolic Syndrome on the Characteristics of Coronary Plaques Using Computed Tomography Angiography

Impact of Body Mass Index and Metabolic Syndrome on the Characteristics of Coronary Plaques Using Computed Tomography Angiography Impact of Body Mass Index and Metabolic Syndrome on the Characteristics of Coronary Plaques Using Computed Tomography Angiography Cardiovascular Division, Faculty of Medicine, University of Tsukuba Akira

More information

ATHEROSCLEROTIC cardiovascular complications are the leading cause of. Diabetes Mellitus Has an Additional Effect on Coronary Artery Disease

ATHEROSCLEROTIC cardiovascular complications are the leading cause of. Diabetes Mellitus Has an Additional Effect on Coronary Artery Disease Diabetes Mellitus Has an Additional Effect on Coronary Artery Disease To Decrease Plasma Adiponectin Levels Kuei-Chuan CHAN, 1 MD, Hsi-Hsien CHOU, 1 PhD, Der-Jinn WU, 1 PhD, Yi-Liang WU, 1 MD, and Chien-Ning

More information

International Journal of Current Research in Medical Sciences

International Journal of Current Research in Medical Sciences International Journal of Current Research in Medical Sciences ISSN: 2454-5716 www.ijcrims.com Coden: IJCRPP(USA) Research Article http://s-o-i.org/1.15/ijcrms-2016-2-1-5 How Raised Homocysteine is Correlated

More information

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD

More information

Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD

Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD 1 Preclinical? No symptoms No physical findings No diagnostic ECG findings No chest X-ray X findings No diagnostic events 2

More information

Patient referral for elective coronary angiography: challenging the current strategy

Patient referral for elective coronary angiography: challenging the current strategy Patient referral for elective coronary angiography: challenging the current strategy M. Santos, A. Ferreira, A. P. Sousa, J. Brito, R. Calé, L. Raposo, P. Gonçalves, R. Teles, M. Almeida, M. Mendes Cardiology

More information

Study of serum Lipid Profile patterns of Indian population in young Ischaemic Heart Disease

Study of serum Lipid Profile patterns of Indian population in young Ischaemic Heart Disease Original article: Study of serum Lipid Profile patterns of Indian population in young Ischaemic Heart Disease Dr Sonu Yadav, Dr Abhijit Nikam, Dr Vivek Chiddarwar, Dr A L Kakrani Department of Medicine,

More information

The Metabolic Syndrome: Is It A Valid Concept? YES

The Metabolic Syndrome: Is It A Valid Concept? YES The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA

More information

Homocysteine Level According to Some Cardiac Risk Factors and Extent of Coronary Disease

Homocysteine Level According to Some Cardiac Risk Factors and Extent of Coronary Disease 23 J Cardiovasc Thorac Res 2011; 3 (1): 23-27 http://jcvtr.tbzmed.ac.ir Homocysteine Level According to Some Cardiac Risk Factors and Extent of Coronary Disease Sepideh Sokhanvar 1, Mohammad Kiani 1, Nouraddin

More information

Key words: Risk factor. Hyperhomocysteinemia. Ischemic heart disease. Smoking.

Key words: Risk factor. Hyperhomocysteinemia. Ischemic heart disease. Smoking. j c p s p September 2004 Volume 14 Number 09 September 2004 Home JCPSP Home Sep JCPSP Contents Email JCPSP HYPERHOMOCYSTEINEMIA AS A RISK FACTOR FOR ISCHEMIC HEART DISEASE Muhammad Aamir, Abdus Sattar,*

More information

National public health campaigns have attempted

National public health campaigns have attempted WINTER 2005 PREVENTIVE CARDIOLOGY 11 CLINICAL STUDY Knowledge of Cholesterol Levels and Targets in Patients With Coronary Artery Disease Susan Cheng, MD; 1,2 Judith H. Lichtman, MPH, PhD; 3 Joan M. Amatruda,

More information

Serum Total Homocysteine and Coronary Heart Disease

Serum Total Homocysteine and Coronary Heart Disease International Journal of Epidemiology O International Eptctemlotoglcal Association 1995 Vol. 24, No. 4 Printed In Great Britain Serum Total Homocysteine and Coronary Heart Disease EGIL ARNESEN,* HELGA

More information

Homocysteine is an amino acid produced as an intermediate

Homocysteine is an amino acid produced as an intermediate CLINICAL REVIEW Homocysteine and Vascular Disease Christopher A. Friedrich, MD, PhD, and Daniel J. Rader, MD Homocysteine is an amino acid produced as an intermediate product in the metabolism of methionine,

More information

Clinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease

Clinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease Cronicon OPEN ACCESS EC NEUROLOGY Research Article Clinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease Jin Ok Kim, Hyung-IL Kim, Jae Guk Kim, Hanna Choi, Sung-Yeon

More information

Laboratory Bulletin...

Laboratory Bulletin... Laboratory Bulletin... Updates and Information from Rex Healthcare and Rex Outreach September 1997 Issue Number 24 Homocysteine and vascular risk Introduction: This past June, the New England Journal of

More information

Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome

Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Helder Dores, Luís Bronze Carvalho, Ingrid Rosário, Sílvio Leal, Maria João

More information

Lipid Markers. Independent Risk Factors. Insulin Resistance Score by Lipid Fractionation

Lipid Markers. Independent Risk Factors. Insulin Resistance Score by Lipid Fractionation Patient: SAMPLE PATIENT DOB: Sex: MRN: 3701 CV Health Plus Genomics - Plasma, Serum & Buccal Swab Methodology: Chemiluminescent, Enzymatic, Immunoturbidimetric, NMR and PCR Lipid Markers Cholesterol LDL-

More information

ETHNIC AND SEX DIFFERENCES IN DISEASE BURDEN IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY: THE CONFOUNDING INFLUENCE OF OBESITY

ETHNIC AND SEX DIFFERENCES IN DISEASE BURDEN IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY: THE CONFOUNDING INFLUENCE OF OBESITY ETHNIC AND SEX DIFFERENCES IN DISEASE BURDEN IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY: THE CONFOUNDING INFLUENCE OF OBESITY Background: Data from cohort studies, predominantly in Caucasians, have identified

More information

Dyslipidemia in the light of Current Guidelines - Do we change our Practice?

Dyslipidemia in the light of Current Guidelines - Do we change our Practice? Dyslipidemia in the light of Current Guidelines - Do we change our Practice? Dato Dr. David Chew Soon Ping Senior Consultant Cardiologist Institut Jantung Negara Atherosclerotic Cardiovascular Disease

More information

Which CVS risk reduction strategy fits better to carotid US findings?

Which CVS risk reduction strategy fits better to carotid US findings? Which CVS risk reduction strategy fits better to carotid US findings? Dougalis A, Soulaidopoulos S, Cholongitas E, Chalevas P, Vettas Ch, Doumtsis P, Vaitsi K, Diavasti M, Mandala E, Garyfallos A 4th Department

More information

Coronary artery disease in twins

Coronary artery disease in twins DAVID R HOLMES JR, ARTHUR J KENNEL, HUGH C SMITH, HYMIE GORDON, S BREANNDAN MOORE Br Heart J 1981; 45: 193-7 From the Division of Cardiovascular Diseases and Internal Medicine, the Division of Community

More information

Coronary Spasm as a Cause of Coronary Thrombosis and Myocardial Infarction

Coronary Spasm as a Cause of Coronary Thrombosis and Myocardial Infarction Case Reports Coronary Spasm as a Cause of Coronary Thrombosis and Myocardial Infarction Masashi HORIMOTO, M.D., Takashi TAKENAKA, M.D., Keiichi IGARASHI, M.D. Masafumi FUJIWARA, M.D., and Sanjay BATRA,

More information

JUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study

JUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study Panel Discussion: Literature that Should Have an Impact on our Practice: The Study Kaiser COAST 11 th Annual Conference Maui, August 2009 Robert Blumberg, MD, FACC Ralph Brindis, MD, MPH, FACC Primary

More information

DECLARATION OF CONFLICT OF INTEREST. None

DECLARATION OF CONFLICT OF INTEREST. None DECLARATION OF CONFLICT OF INTEREST None BURDEN OF CORONARY ARTERY DISEASE IN DIABETES IN INDIA Amal Kumar Banerjee MD, DM,FACC,FESC,FACP,FAPSC,FICC President Association of Physicians of India SAARC Cardiac

More information

Vascular complications in patients with hyperhomocysteinemia

Vascular complications in patients with hyperhomocysteinemia Relation of a Common Methylenetetrahydrofolate Reductase Mutation and Plasma Homocysteine With Intimal Hyperplasia After Coronary Stenting Tai Kosokabe, MD; Kenji Okumura, MD; Takahito Sone, MD; Junichiro

More information

The New Gold Standard for Lipoprotein Analysis. Advanced Testing for Cardiovascular Risk

The New Gold Standard for Lipoprotein Analysis. Advanced Testing for Cardiovascular Risk The New Gold Standard for Lipoprotein Analysis Advanced Testing for Cardiovascular Risk Evolution of Lipoprotein Testing The Lipid Panel Total Cholesterol = VLDL + LDL + HDL Evolution of Lipoprotein Testing

More information

Page: 1 of 11. Homocysteine Testing in the Screening, Diagnosis and Management of Cardiovascular Disease

Page: 1 of 11. Homocysteine Testing in the Screening, Diagnosis and Management of Cardiovascular Disease Last Review Status/Date: June 2015 Page: 1 of 11 Diagnosis and Management of Description Homocysteine is an amino acid found in the blood; levels are inversely correlated with folate levels. Homocysteine

More information

Echocardiography analysis in renal transplant recipients

Echocardiography analysis in renal transplant recipients Original Research Article Echocardiography analysis in renal transplant recipients S.A.K. Noor Mohamed 1*, Edwin Fernando 2, 1 Assistant Professor, 2 Professor Department of Nephrology, Govt. Stanley Medical

More information

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION 2 Hyperlipidemia Andrew Cohen, MD and Neil S. Skolnik, MD CONTENTS INTRODUCTION RISK CATEGORIES AND TARGET LDL-CHOLESTEROL TREATMENT OF LDL-CHOLESTEROL SPECIAL CONSIDERATIONS OLDER AND YOUNGER ADULTS ADDITIONAL

More information

Established Risk Factors for Coronary Heart Disease (CHD)

Established Risk Factors for Coronary Heart Disease (CHD) Getting Patients to Make Small Lifestyle Changes That Result in SIGNIFICANT Improvements in Health - Prevention of Diabetes and Obesity for Better Health Maureen E. Mays, MD, MS, FACC Director ~ Portland

More information

Diabetes and Heart Disease. Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center

Diabetes and Heart Disease. Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center Diabetes and Heart Disease Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center No conflicts of interest or financial relationships to disclose. 2 What s the problem??

More information

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor 76 year old female Prior Hypertension, Hyperlipidemia, Smoking On Hydrochlorothiazide, Atorvastatin New onset chest discomfort; 2 episodes in past 24 hours Heart rate 122/min; BP 170/92 mm Hg, Killip Class

More information

Soo LIM, MD, PHD Internal Medicine Seoul National University Bundang Hospital

Soo LIM, MD, PHD Internal Medicine Seoul National University Bundang Hospital Soo LIM, MD, PHD Internal Medicine Seoul National University Bundang Hospital 1. Importance of Lowering LDL-Cholesterol in Diabetes Patients & Lipid Guidelines Prevalence of dyslipidemia in Korea Prevalence

More information

Investigating the Frequency of Atherosclerosis Risk Factors in Patients Suffering from X Syndrome

Investigating the Frequency of Atherosclerosis Risk Factors in Patients Suffering from X Syndrome Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2016, 5, 10:84-90 Investigating the Frequency of Atherosclerosis Risk Factors in Patients

More information

SUPPLEMENTAL MATERIAL

SUPPLEMENTAL MATERIAL SUPPLEMENTAL MATERIAL A Meta-analysis of LDL-C, non-hdl-c, and apob as markers of cardiovascular risk. Slide # Contents 2 Table A1. List of candidate reports 8 Table A2. List of covariates/model adjustments

More information

Comprehensive Treatment for Dyslipidemias. Eric L. Pacini, MD Oregon Cardiology 2012 Cardiovascular Symposium

Comprehensive Treatment for Dyslipidemias. Eric L. Pacini, MD Oregon Cardiology 2012 Cardiovascular Symposium Comprehensive Treatment for Dyslipidemias Eric L. Pacini, MD Oregon Cardiology 2012 Cardiovascular Symposium Primary Prevention 41 y/o healthy male No Medications Normal BP, Glucose and BMI Social History:

More information

THE EFFECT OF VITAMIN-C THERAPY ON HYPERGLYCEMIA, HYPERLIPIDEMIA AND NON HIGH DENSITY LIPOPROTEIN LEVEL IN TYPE 2 DIABETES

THE EFFECT OF VITAMIN-C THERAPY ON HYPERGLYCEMIA, HYPERLIPIDEMIA AND NON HIGH DENSITY LIPOPROTEIN LEVEL IN TYPE 2 DIABETES Int. J. LifeSc. Bt & Pharm. Res. 2013 Varikasuvu Seshadri Reddy et al., 2013 Review Article ISSN 2250-3137 www.ijlbpr.com Vol. 2, No. 1, January 2013 2013 IJLBPR. All Rights Reserved THE EFFECT OF VITAMIN-C

More information

Statistical Fact Sheet Populations

Statistical Fact Sheet Populations Statistical Fact Sheet Populations At-a-Glance Summary Tables Men and Cardiovascular Diseases Mexican- American Males Diseases and Risk Factors Total Population Total Males White Males Black Males Total

More information

High Blood Pressure in Irish Adults

High Blood Pressure in Irish Adults High Blood Pressure in Irish Adults Preliminary findings and lessons learned from two JINGO cohorts Helene McNulty Northern Ireland Centre for Food and Health (NICHE) University of Ulster Mortality due

More information

Impact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients

Impact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients 2012 International Conference on Life Science and Engineering IPCBEE vol.45 (2012) (2012) IACSIT Press, Singapore DOI: 10.7763/IPCBEE. 2012. V45. 14 Impact of Physical Activity on Metabolic Change in Type

More information

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Latest Insights from the JUPITER Study John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Inflammation, hscrp, and Vascular Prevention

More information

The association between serum uric acid level and coronary artery disease

The association between serum uric acid level and coronary artery disease ORIGINAL PAPER The association between serum uric acid level and coronary artery disease O. Sinan Deveci, 1 G. Kabakci, 2 S. Okutucu, 2 E. Tulumen, 2 H. Aksoy, 2 E. Baris Kaya, 2 B. Evranos, 2 K. Aytemir,

More information

Coronary Artery Calcium Score

Coronary Artery Calcium Score Coronary Artery Calcium Score August 19, 2014 by Axel F. Sigurdsson MD 174 Comments essential for living organisms. Calcium is a chemical element that is Most of the calcium within the human body is found

More information

Angiographic comparison of coronary artery disease

Angiographic comparison of coronary artery disease Postgrad Med J (1994) 70, 625-630 The Fellowship of Postgraduate Medicine, 1994 Angiographic comparison of coronary artery disease between Asians and Caucasians J. Dhawan and C.L. Bray Department ofcardiology,

More information

Scope of the talk. Riboflavin, other dairy B vitamins and cardiovascular health. Epidemiology of milk consumption and CVD

Scope of the talk. Riboflavin, other dairy B vitamins and cardiovascular health. Epidemiology of milk consumption and CVD Riboflavin, other dairy B vitamins and cardiovascular health Professor Hilary J Powers University of Sheffield United Kingdom Scope of the talk Importance of dairy products to B vitamin intakes Epidemiological

More information

The inhibition of CETP: From simply raising HDL-c to promoting cholesterol efflux and lowering of atherogenic lipoproteins Prof Dr J Wouter Jukema

The inhibition of CETP: From simply raising HDL-c to promoting cholesterol efflux and lowering of atherogenic lipoproteins Prof Dr J Wouter Jukema The inhibition of CETP: From simply raising HDL-c to promoting cholesterol efflux and lowering of atherogenic lipoproteins Prof Dr J Wouter Jukema Dept Cardiology, Leiden University Medical Center, Leiden,

More information

New Insight about FFR and IVUS MLA

New Insight about FFR and IVUS MLA New Insight about FFR and IVUS MLA Can IVUS MLA Predict FFR

More information